COMMUNIQUÉS West-GlobeNewswire

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
15/10/2024
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 - - RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) Upon Marketing [...]
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
15/10/2024
U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference in Early 2025 BRAINTREE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( [...]
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
15/10/2024
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced the appointment of [...]
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024
15/10/2024
Webinar to focus on a nephrologist’s perspective on the use of FUROSCIX for fluid overload in heart failure and potential use in chronic kidney disease BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- [...]
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
14/10/2024
-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius -- -- National Reimbursement Payment Determination from CMS for its PoNS [...]
Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024
14/10/2024
Data presentations highlight the results for FILSPARI ® (sparsentan), the only approved kidney-targeted medicine for IgA nephropathy, when used as a first-line treatment, and in combination with other therapies Late- [...]
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
14/10/2024
Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024
14/10/2024
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer
14/10/2024
-Seasoned Franchise Executive to also Join the Company’s Board of Directors - SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest [...]
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
14/10/2024
Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology [...]
Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
14/10/2024
DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial
14/10/2024
The study found improvements in reading speed, vision-related quality of life, and suggested potential benefits of an interventional approach for patients with dry eye disease MENLO PARK, Calif., Oct. 14, 2024 (GLOBE [...]
The Association of American Physicians and Surgeons (AAPS) Sues to Block Expansion of the Federal Police State
14/10/2024
TUCSON, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (“AAPS”) served a lawsuit on Oct 11, seeking to block the upcoming requirement that tens of millions Americans provide [...]
Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
14/10/2024
Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva annonce la mise à disposition d'un prospectus dans le cadre de son financement par l’émission d’actions ordinaires et de bons de souscription d’action préfinancés
14/10/2024
Daix (France), Long Island City (New York, États-Unis), le 14 octobre 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]
Norton Healthcare acquires groundbreaking focused ultrasound technology
14/10/2024
Norton Neuroscience Institute first in Kentucky with incisionless surgery for essential tremor, tremor-dominant Parkinson’s disease LOUISVILLE, Ky., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Norton Neuroscience Institute is the [...]
Ipsen receives its second Shingo Prize for operational excellence
14/10/2024
Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patients Ipsen’s first Shingo Prize was received by its production site in Signes, France in 2020, followed [...]
Ipsen reçoit un deuxième prix Shingo pour son excellence opérationnelle
14/10/2024
Ipsen est la première société pharmaceutique au monde à avoir reçu le prix Shingo pour deux sites de production de médicaments destinés aux patients. Ipsen a reçu son premier prix Shingo pour son site de production de [...]
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical
14/10/2024
TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) hereby announces that it has entered into a debt-for-equity swap agreement (the " Debt Swap Agreement ") [...]

Pages